Treatment Planning Systems and Advanced lmage Processing - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512251087

Publication Date:

December 10, 2024

Pages:

113

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Treatment Planning Systems and Advanced lmage Processing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Treatment Planning Systems and Advanced lmage Processing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Treatment Planning Systems and Advanced lmage Processing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Treatment Planning Systems and Advanced lmage Processing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Treatment Planning Systems and Advanced lmage Processing include Accuray, Incorporated, Elekta, Koninklijke Philips, NV, RaySearch, Laboratories, Varian Medical and Systems, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Treatment Planning Systems and Advanced lmage Processing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Treatment Planning Systems and Advanced lmage Processing by region & country, by Type, and by Application.
The Treatment Planning Systems and Advanced lmage Processing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatment Planning Systems and Advanced lmage Processing.
麻豆原创 Segmentation
By Company
Accuray
Incorporated
Elekta
Koninklijke Philips
NV
RaySearch
Laboratories
Varian Medical
Systems
Brainlab
Prowess
DOSIsoft SA
Viewray
MIM Software
Segment by Type:
Treatment Planning Software
Advanced lmage Processing Software
Segment by Application
Adaptive Radiotherapy
Image Registration Verification
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Treatment Planning Systems and Advanced lmage Processing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Treatment Planning Systems and Advanced lmage Processing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Treatment Planning Systems and Advanced lmage Processing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Treatment Planning Systems and Advanced lmage Processing Product Introduction
1.2 Global Treatment Planning Systems and Advanced lmage Processing 麻豆原创 Size Forecast
1.3 Treatment Planning Systems and Advanced lmage Processing 麻豆原创 Trends & Drivers
1.3.1 Treatment Planning Systems and Advanced lmage Processing Industry Trends
1.3.2 Treatment Planning Systems and Advanced lmage Processing 麻豆原创 Drivers & Opportunity
1.3.3 Treatment Planning Systems and Advanced lmage Processing 麻豆原创 Challenges
1.3.4 Treatment Planning Systems and Advanced lmage Processing 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Treatment Planning Systems and Advanced lmage Processing Players Revenue Ranking (2023)
2.2 Global Treatment Planning Systems and Advanced lmage Processing Revenue by Company (2019-2024)
2.3 Key Companies Treatment Planning Systems and Advanced lmage Processing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Treatment Planning Systems and Advanced lmage Processing Product Offered
2.5 Key Companies Time to Begin Mass Production of Treatment Planning Systems and Advanced lmage Processing
2.6 Treatment Planning Systems and Advanced lmage Processing 麻豆原创 Competitive Analysis
2.6.1 Treatment Planning Systems and Advanced lmage Processing 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Treatment Planning Systems and Advanced lmage Processing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatment Planning Systems and Advanced lmage Processing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Treatment Planning Software
3.1.2 Advanced lmage Processing Software
3.2 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Type
3.2.1 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Treatment Planning Systems and Advanced lmage Processing Sales Value, by Type (2019-2030)
3.2.3 Global Treatment Planning Systems and Advanced lmage Processing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adaptive Radiotherapy
4.1.2 Image Registration Verification
4.1.3 Others
4.2 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Application
4.2.1 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Treatment Planning Systems and Advanced lmage Processing Sales Value, by Application (2019-2030)
4.2.3 Global Treatment Planning Systems and Advanced lmage Processing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Region
5.1.1 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Region (2019-2024)
5.1.3 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Region (2025-2030)
5.1.4 Global Treatment Planning Systems and Advanced lmage Processing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
5.2.2 North America Treatment Planning Systems and Advanced lmage Processing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
5.3.2 Europe Treatment Planning Systems and Advanced lmage Processing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
5.4.2 Asia Pacific Treatment Planning Systems and Advanced lmage Processing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
5.5.2 South America Treatment Planning Systems and Advanced lmage Processing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
5.6.2 Middle East & Africa Treatment Planning Systems and Advanced lmage Processing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Treatment Planning Systems and Advanced lmage Processing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Treatment Planning Systems and Advanced lmage Processing Sales Value
6.3 United States
6.3.1 United States Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
6.3.2 United States Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Treatment Planning Systems and Advanced lmage Processing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
6.4.2 Europe Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Treatment Planning Systems and Advanced lmage Processing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
6.5.2 China Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Treatment Planning Systems and Advanced lmage Processing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
6.6.2 Japan Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Treatment Planning Systems and Advanced lmage Processing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
6.7.2 South Korea Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Treatment Planning Systems and Advanced lmage Processing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
6.8.2 Southeast Asia Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Treatment Planning Systems and Advanced lmage Processing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Treatment Planning Systems and Advanced lmage Processing Sales Value, 2019-2030
6.9.2 India Treatment Planning Systems and Advanced lmage Processing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Treatment Planning Systems and Advanced lmage Processing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Accuray
7.1.1 Accuray Profile
7.1.2 Accuray Main Business
7.1.3 Accuray Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.1.4 Accuray Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.1.5 Accuray Recent Developments
7.2 Incorporated
7.2.1 Incorporated Profile
7.2.2 Incorporated Main Business
7.2.3 Incorporated Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.2.4 Incorporated Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.2.5 Incorporated Recent Developments
7.3 Elekta
7.3.1 Elekta Profile
7.3.2 Elekta Main Business
7.3.3 Elekta Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.3.4 Elekta Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.3.5 Koninklijke Philips Recent Developments
7.4 Koninklijke Philips
7.4.1 Koninklijke Philips Profile
7.4.2 Koninklijke Philips Main Business
7.4.3 Koninklijke Philips Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.4.4 Koninklijke Philips Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.4.5 Koninklijke Philips Recent Developments
7.5 NV
7.5.1 NV Profile
7.5.2 NV Main Business
7.5.3 NV Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.5.4 NV Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.5.5 NV Recent Developments
7.6 RaySearch
7.6.1 RaySearch Profile
7.6.2 RaySearch Main Business
7.6.3 RaySearch Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.6.4 RaySearch Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.6.5 RaySearch Recent Developments
7.7 Laboratories
7.7.1 Laboratories Profile
7.7.2 Laboratories Main Business
7.7.3 Laboratories Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.7.4 Laboratories Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.7.5 Laboratories Recent Developments
7.8 Varian Medical
7.8.1 Varian Medical Profile
7.8.2 Varian Medical Main Business
7.8.3 Varian Medical Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.8.4 Varian Medical Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.8.5 Varian Medical Recent Developments
7.9 Systems
7.9.1 Systems Profile
7.9.2 Systems Main Business
7.9.3 Systems Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.9.4 Systems Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.9.5 Systems Recent Developments
7.10 Brainlab
7.10.1 Brainlab Profile
7.10.2 Brainlab Main Business
7.10.3 Brainlab Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.10.4 Brainlab Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.10.5 Brainlab Recent Developments
7.11 Prowess
7.11.1 Prowess Profile
7.11.2 Prowess Main Business
7.11.3 Prowess Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.11.4 Prowess Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.11.5 Prowess Recent Developments
7.12 DOSIsoft SA
7.12.1 DOSIsoft SA Profile
7.12.2 DOSIsoft SA Main Business
7.12.3 DOSIsoft SA Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.12.4 DOSIsoft SA Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.12.5 DOSIsoft SA Recent Developments
7.13 Viewray
7.13.1 Viewray Profile
7.13.2 Viewray Main Business
7.13.3 Viewray Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.13.4 Viewray Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.13.5 Viewray Recent Developments
7.14 MIM Software
7.14.1 MIM Software Profile
7.14.2 MIM Software Main Business
7.14.3 MIM Software Treatment Planning Systems and Advanced lmage Processing Products, Services and Solutions
7.14.4 MIM Software Treatment Planning Systems and Advanced lmage Processing Revenue (US$ Million) & (2019-2024)
7.14.5 MIM Software Recent Developments
8 Industry Chain Analysis
8.1 Treatment Planning Systems and Advanced lmage Processing Industrial Chain
8.2 Treatment Planning Systems and Advanced lmage Processing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Treatment Planning Systems and Advanced lmage Processing Sales Model
8.5.2 Sales Channel
8.5.3 Treatment Planning Systems and Advanced lmage Processing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Accuray
Incorporated
Elekta
Koninklijke Philips
NV
RaySearch
Laboratories
Varian Medical
Systems
Brainlab
Prowess
DOSIsoft SA
Viewray
MIM Software

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.